G47.33
Obstructive sleep apnea (adult) (pediatric)
Obstructive sleep apnea (OSA) is a common and potentially serious sleep disorder where breathing repeatedly stops and starts during sleep. This occurs because the throat muscles intermittently relax and block the airway. In adults, the most common cause is excess weight and obesity, leading to soft tissue collapse in the pharynx. In pediatric patients, the most frequent etiology is adenotonsillar hypertrophy. The resulting episodes of apnea (total cessation of airflow) and hypopnea (partial reduction in airflow) lead to fragmented sleep and intermittent hypoxemia. If left untreated, OSA is associated with significantly increased risks for cardiovascular diseases including hypertension, myocardial infarction, and stroke, as well as metabolic dysfunction like insulin resistance and type 2 diabetes.
Clinical Symptoms
- Loud snoring
- Episodes in which you stop breathing during sleep (witnessed by another person)
- Gasping or choking sounds during sleep
- Excessive daytime sleepiness (hypersomnolence)
- Morning headache
- Waking up with a dry mouth or sore throat
- Insomnia or difficulty staying asleep
- Abrupt awakenings accompanied by gasping or choking
- Irritability and mood swings
- Difficulty concentrating or cognitive impairment
- Decreased libido or erectile dysfunction
- Nocturia (frequent nighttime urination)
- Mouth breathing (especially in children)
- Restless sleep or unusual sleeping positions (especially in children)
- Hyperactivity or behavioral problems (pediatric presentation)
Common Causes
- Excess weight and obesity (primary risk factor in adults)
- Adenotonsillar hypertrophy (primary cause in children)
- Narrowed airway due to inherited traits or craniofacial abnormalities
- Male gender (though risk increases in post-menopausal women)
- Advanced age
- Family history of sleep apnea
- Use of alcohol, sedatives, or tranquilizers which relax throat muscles
- Smoking, which increases inflammation and fluid retention in the upper airway
- Nasal congestion from allergies or anatomical issues (e.g., deviated septum)
- Medical conditions such as congestive heart failure, type 2 diabetes, and polycystic ovary syndrome
- Endocrine disorders like hypothyroidism or acromegaly
- Macroglossia (enlarged tongue)
- Retrognathia or micrognathia (recessed or small jaw)
Documentation & Coding Tips
Explicitly document the Apnea-Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) results from the diagnostic polysomnography to establish severity.
Example: Patient presents for follow-up of obstructive sleep apnea (adult). Diagnostic polysomnography performed on June 12, 2025, revealed an AHI of 28 events per hour, consistent with moderate OSA. Patient reports persistent daytime somnolence despite adherence to CPAP at 10 cm H2O for 6 hours nightly. Billing Focus: Identification of severity and treatment modality. Risk Adjustment: Linked to increased cardiovascular risk profile.
Billing Focus: Documentation of AHI/RDI values and diagnostic test dates to support medical necessity for CPAP (94660) and ongoing supplies.
Document the relationship between Obstructive Sleep Apnea and comorbid conditions such as morbid obesity, hypertension, or atrial fibrillation.
Example: Assessment: Obstructive sleep apnea (adult), chronic, stable on CPAP. Comorbid morbid obesity with BMI of 42.5. OSA is likely a contributing factor to the patient's refractory essential hypertension. Plan: Continue CPAP; refer to bariatric surgery for weight management consultation. Billing Focus: Co-occurring condition specificity (E66.01, I10). Risk Adjustment: Morbid obesity and OSA together significantly increase the risk adjustment factor (RAF) score.
Billing Focus: Ensures all related chronic conditions are captured to justify higher-level E/M coding (99214) based on complexity.
In pediatric cases, specify anatomical causes such as tonsillar or adenoid hypertrophy that necessitate surgical intervention.
Example: Pediatric patient with obstructive sleep apnea (pediatric) secondary to grade 4+ tonsillar hypertrophy. Mother reports frequent gasping and witnessed apneas during sleep. Physical exam confirms enlarged tonsils obstructing the oropharynx. Billing Focus: Anatomical site specificity for surgical planning. Risk Adjustment: Pediatric OSA often requires different resource allocation and surgical intervention compared to adult OSA.
Billing Focus: Supports the medical necessity for CPT 42820 (Tonsillectomy and adenoidectomy, age younger than 12).
Note the presence of Sleep-Related Hypoventilation or Hypoxemia if documented during the sleep study, as these are distinct clinical components.
Example: Patient with obstructive sleep apnea (adult) and documented nocturnal hypoxemia with oxygen saturation dropping to 82 percent for 15 percent of the total sleep time. Home oxygen at 2L via nasal cannula prescribed for use with CPAP. Billing Focus: Support for supplemental oxygen therapy. Risk Adjustment: Hypoxemia increases the severity tier and management complexity.
Billing Focus: Provides evidence for the prescription of E1390 (Oxygen concentrator) and associated supplies.
Document CPAP or BiPAP adherence data and the patient's clinical response to therapy at each encounter.
Example: CPAP compliance report reviewed: Patient has used device 92 percent of nights for over 4 hours. Epworth Sleepiness Scale score improved from 15 at baseline to 6 today. Obstructive sleep apnea (adult) remains well-controlled. Billing Focus: Documentation of adherence for continued insurance coverage of DME. Risk Adjustment: Reflects managed chronic condition status.
Billing Focus: Required for the 90-day compliance check and ongoing DME reimbursement for masks and filters.
Relevant CPT Codes
-
95810 - Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist
Required to calculate the AHI and confirm the G47.33 diagnosis.
-
95811 - Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bi-level ventilation, attended by a technologist
Used once G47.33 is suspected or confirmed to determine treatment parameters.
-
95800 - Sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time
A cost-effective method for diagnosing G47.33 in adults with high pre-test probability.
-
94660 - Continuous positive airway pressure (CPAP) delivery, initiation and subsequent setup; education and training of patient
This is the primary treatment procedure following a G47.33 diagnosis.
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a Low level of medical decision making
Used for routine follow-up of stable OSA patients with no significant complications.
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a Moderate level of medical decision making
Used for OSA patients with poorly controlled symptoms or multiple comorbidities like obesity and heart failure.
-
42820 - Tonsillectomy and adenoidectomy; younger than age 12
First-line treatment for G47.33 in the pediatric population when hypertrophy is present.
-
31231 - Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)
Used to evaluate nasal obstruction that may contribute to OSA or CPAP intolerance.
-
95782 - Polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, attended by a technologist
The definitive diagnostic tool for G47.33 in young children.
-
94662 - Continuous negative airway pressure (CNAP) delivery, initiation and subsequent setup; education and training of patient
Used in specific cases where negative pressure therapy is selected over CPAP for OSA.
Related Diagnoses
- G47.30 - Sleep apnea, unspecified
- G47.31 - Central sleep apnea
- E66.01 - Morbid (severe) obesity due to excess calories
- I10 - Essential (primary) hypertension
- I27.23 - Pulmonary hypertension due to lung diseases and hypoxia
- R06.83 - Snoring
- F51.01 - Primary insomnia
- G47.10 - Hypersomnia, unspecified
- J35.1 - Hypertrophy of tonsils
- Z99.81 - Dependence on supplemental oxygen